Abnoba GmbH
🇩🇪Germany
Clinical Trials
5
Active:2
Completed:2
Trial Phases
3 Phases
Phase 1:3
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 3
1 (20.0%)Phase 4
1 (20.0%)Therapeutic Instillation of Mistletoe
Phase 3
Active, not recruiting
- Conditions
- Superficial Bladder Cancer
- Interventions
- Drug: abnobaVISCUM 900
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- Abnoba Gmbh
- Target Recruit Count
- 548
- Registration Number
- NCT02106572
- Locations
- 🇪🇬
Theodor Bilharz Research Institute, Giza, Egypt
🇩🇪Clinic of Urology of the University Hospital of Essen, Essen, Germany
🇩🇪Urologische Gemeinschaftspraxis, Heinsberg, Germany
Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer
Phase 1
Completed
- Conditions
- Superficial Bladder Cancer
- Interventions
- Drug: abnobaVISCUM Fraxini
- First Posted Date
- 2013-12-10
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Abnoba Gmbh
- Target Recruit Count
- 37
- Registration Number
- NCT02007005
- Locations
- 🇪🇬
Theodor Bilharz Research Institute, Giza, Egypt
🇩🇪Clinic of Urology of the University Hospital of Essen, Essen, Germany
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2012-11-07
- Lead Sponsor
- Abnoba Gmbh
- Target Recruit Count
- 32
- Registration Number
- NCT01401075
- Locations
- 🇰🇷
ASAN Medical Center, Seoul, Korea, Republic of
News
No news found